What is the NOAEL for Alpha-Arbutin?
Alpha-Arbutin has 100 NOAEL studies in the database. The lowest reported value is 2 %. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Also known as: UNII-72VUP07IT5
CAS 84380-01-8
Alpha-Arbutin (CAS 84380-01-8) is a chemical substance. Key regulatory status: REACH registered, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, SCCS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; pharmaceutical | DrugBank | DrugBank |
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 2 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 9 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =15 | mg/kg/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =20 | mg/kg/day | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 20 | mg/kg bw/day | - | dermal | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =20 | mg/kg/day | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =74 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw/day | - | dermal | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw/day | - | dermal | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 344 | - | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 72VUP07IT5 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 72VUP07IT5 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 72VUP07IT5 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =2 | % | NOAEL | - | - | SCCS_vision_codex |
| =2 | % | NOAEL | - | - | SCCS_vision_codex |
| =2 | % | NOAEL | - | - | SCCS_vision_codex |
| =2 | % | NOAEL | - | - | SCCS_vision_codex |
| =3.3 | - | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =3.3 | - | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =3.3 | - | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =3.3 | - | NOAEL | oral | guinea pig | SCCS_vision_codex |
| =9 | - | NOAEL | - | - | SCCS_vision_codex |
| =9 | - | NOAEL | - | - | SCCS_vision_codex |
| =9 | - | NOAEL | - | - | SCCS_vision_codex |
| =9 | - | NOAEL | - | - | SCCS_vision_codex |
| =15 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | - | - | SCCS_vision_codex |
| =15 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =15 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | - | - | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | - | - | SCCS_vision_codex |
| =15 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =15 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =15 | mg/kg bw/d | NOAEL | - | - | SCCS_vision_codex |
| =20 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =20 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =20 | % | NOAEL | dermal | guinea pig | SCCS_vision_codex |
| =20 | mg/kg bw/d | NOAEL | - | - | SCCS_vision_codex |
| =20 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =20 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =20 | % | NOAEL | dermal | guinea pig | SCCS_vision_codex |
| =20 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =20 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =20 | mg/kg bw | NOAEL | oral | - | SCCS_vision_codex |
| =20 | % | NOAEL | dermal | guinea pig | SCCS_vision_codex |
Showing 50 of 100 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-hydroxyphenyl-alpha-D-glucopyranoside | 440-470-8 | ECHA overview → |
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1552/15 | 27 May 2015 | safe with restrictions | 2% face cream; 0.5% body lotion | Hydroquinone release potential; limited data on other product types; precursor to updated SCCS/1642/22 |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Alpha-Arbutin has 100 NOAEL studies in the database. The lowest reported value is 2 %. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Alpha-Arbutin appears on 1 regulatory/inventory list including Canada; pharmaceutical. Source: EPA CPDat.
Yes, Alpha-Arbutin is also indexed as a cosmetic ingredient under the name Alpha-Arbutin. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Alpha-Arbutin also appears in cosmetics, pharmaceutical databases.